Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Goodwill and Intangible Assets (Tables)

Note 8 - Goodwill and Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2024

Notes Tables

Schedule of Finite-Lived Intangible Assets [Table Text Block]

		*March 31, 2024*
		*Gross Carrying Amount*				*Accumulated Amortization*				*Net Carrying Amount*
Developed technology		$	2,310			$	(382	)		$	1,928
Trade name			2,310				N/A				2,310
Intellectual property			460				—				460
Customer relationships			140				(23	)			117
Below market lease			20				(20	)			—
Total intangible assets		$	5,240			$	(425	)		$	4,815

		December 31, 2023
		Gross Carrying Amount				Accumulated Amortization				Net Carrying Amount
Developed technology		$	2,310			$	(310	)		$	2,000
Trade name			2,310				N/A				2,310
Intellectual property			460				—				460
Customer relationships			140				(18	)			122
Below market lease			20				(20	)			—
Total intangible assets		$	5,240			$	(348	)		$	4,892

Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

Fiscal Year		*Amount*
2024 - remainder		$	230
2025			345
2026			345
2027			345
2028			345
2029 and thereafter			895
Total		$	2,505